[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349747-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349747-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mast-cells-accumulate-in-the-stroma-of-breast-adenocarcinoma-and-secrete-pro-inflammatory-cytokines-and-tumor-damaging-mediators-could-il-37-and-il-38-play-an-anti-tumor-role","Mast Cells Accumulate in the Stroma of Breast Adenocarcinoma and Secrete Pro-Inflammatory Cytokines and Tumor-Damaging Mediators - Could IL-37 and IL-38 Play an Anti-Tumor Role?","","Tumor tissue is surrounded by mast cells (MCs), which drive inflammatory immune responses through cytokines, proteases, and other mediators. MCs connect innate and adaptive immunity and link to IgE signaling via FcεRI, contributing to inflammation, leukocyte recruitment, tissue swelling, anaphylaxis, and pro-inflammatory cytokine production. In breast cancer, MCs may also modulate acquired immunity, promoting remodeling while inhibiting tumor progression through anti-inflammatory factors. IL-37 and IL-38, anti-inflammatory IL-1 family regulators, could counteract IL-1–triggered inflammatory cascades involving IL-6, TNF, and IL-33. This review synthesizes current insights on how stromal MC accumulation relates to IL-37 and IL-38 and evaluates molecules influencing tumor growth and metastasis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mast-cells-accumulate-in-the-stroma-of-breast-adenocarcinoma-and-secrete-pro-inflammatory-cytokines-and-tumor-damaging-mediators-could-il-37-and-il-38-play-an-anti-tumor-role/349747/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mast-cells-accumulate-in-the-stroma-of-breast-adenocarcinoma-and-secrete-pro-inflammatory-cytokines-and-tumor-damaging-mediators-could-il-37-and-il-38-play-an-anti-tumor-role/349747.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do mast cells (MCs) contribute to inflammation in breast cancer?","Question",{"text":63,"@type":64},"MCs produce cytokines, proteases, and other molecules that promote inflammatory processes such as leukocyte recruitment, tissue swelling, and pro-inflammatory cytokine production in the tumor microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What roles do IL-37 and IL-38 play in inflammatory signaling?",{"text":68,"@type":64},"IL-37 directly reduces inflammation by blocking pathways like NF-κB and MAPK, while IL-38 regulates the IL-36/IL-17 axis. Both can block IL-1 downstream inflammatory cascades.",{"name":70,"@type":61,"acceptedAnswer":71},"Why might blocking IL-1 with IL-37 or IL-38 be a therapeutic strategy?",{"text":72,"@type":64},"The review proposes that IL-1 released downstream of oncogenic activity can trigger inflammation through cytokines such as IL-6, TNF, and IL-33. Using IL-37 or IL-38 to block IL-1 may help counter tumor-associated inflammation, especially when combined with other treatments.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349747,1790755109,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Review  \nMast Cells Accumulate in the Stroma of Breast Adenocarcinoma and Secrete Pro-Inflammatory Cytokines and Tumor-Damaging Mediators: Could IL-37 and IL-38 Play an Anti-Tumor Role?  \nPio Conti 1, *, Carla E. Gallenga 2, Ciro Annicchiarico 3,†, Armando Coppola 4, Raffaello Pellegrino 5, Michelangelo J. Conti 6 and Filiberto Mastrangelo 7  \nAcademic Editor: Atsushi Matsuzawa  \nReceived: 3 November 2025  \nRevised: 10 December 2025  \nAccepted: 26 December 2025  \nPublished: 14 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Immunology Division, Postgraduate Medical School, University of Chieti, 66100 Chieti, Italy  \n2 Section of Ophthalmology, Department of Biomedical Sciences and Specialist Surgery, University of Ferrara, 44121 Ferrara, Italy  \n3 Independent Researcher, 74023 Grottaglie, Italy  \n4 Private Practice, Studio Armando Coppola, Corso Garibaldi 246, 80141 Naples, Italy  \n5 Independent Researcher, Lecce-Castromediano/Cavallino, Via S. Pelico 34, 73100 Lecce, Italy  \n6 Faculty of Medicine, S. Andrea University “La Sapienza”, 00189 Rome, Italy  \n7 Department of Clinical and Experimental Medicine, School of Dentistry, University of Foggia,  \n71100 Foggia, Italy  \n* Correspondence: pioconti@yahoo.it or pioconti@unich.it  \n† Previous affiliation: Faculty of Dentistry, University of Bari, 70100 Bari, Italy.  \nAbstract  \nTumor tissue is surrounded by mast cells (MCs), which participate in the inflammatory immune response by producing cytokines, proteases, and other molecules. MCs are involved in both innate and acquired immunity and are associated with the IgE response through the FcεRI receptor. MCs mediate inflammation in several immune reactions, including acute hyperreactivity, leukocyte recruitment, acute tissue swelling, anaphylaxis, and pro-inflammatory cytokine production. They not only function as pro-inflammatory effector cells but may also contribute to the regulation of the acquired immune response in tumor tissue. Therefore, MCs may mediate immunity in breast cancer by promoting remodelling and counteracting cancer growth. They also produce anti-inflammatory substances, such as histamine, transforming growth factor-β (TGF-β)1, IL-10, and IL-4, which inhibit the acquired immune response and reduce the inflammatory state. IL-37 and IL-38 are novel natural regulators of inflammation and are anti-inflammatory members of the IL-1 family. IL-1, generated by immune cells such as macrophages and lymphocytes, is released downstream of oncogenes in breast cancer, triggering an inflammatory response by stimulating other pro-inflammatory cytokines such as IL-6, tumor necrosis factor (TNF), and IL-33 (an early warning cytokine) . Therefore, blocking IL-1 with IL-37 or IL-38 could represent a novel therapeutic strategy that, when combined with other treatments, could be beneficial in breast cancer. This review focuses on the new discoveries and insights into the role of MCs in breast cancer. We also analyzed molecules that can promote tumor growth and those that can inhibit cancer development and metastasis. This review aims to study the role of MCs accumulated in the stroma of breast adenocarcinoma in relation to secreted anti-inflammatory cytokines, such as IL-37 and IL-38 .  \nKeywords: cancer; mast cell; adenocarcinoma; inflammatory cytokine; anti-inflammatory cytokine  \n1. Introduction  \nRepair and tolerance keep DNA stable, but dysregulation is one of the causes of tumor onset [1] . Cancer is a non-hereditary disease, but some individuals may have a genetic predisposition to develop certain types of tumors. Genetic mutations in DNA can lead to cancer, which may be caused by physical, chemical, biological, or hormonal factors [2] .  \nBreast cancer is prevalent in women, and despite the improvement of therapeutic targets in the last 20 years, its inc","cbCaic2fp5mASHbi","https://ap.wps.com/l/cbCaic2fp5mASHbi","pdf",652943,17,"English","# Introduction\n## Breast cancer context and risk factors\n## Adenocarcinoma microenvironment and immune evasion\n## IL-37 and IL-38 as anti-tumor regulators","[{\"question\":\"How do mast cells (MCs) contribute to inflammation in breast cancer?\",\"answer\":\"MCs produce cytokines, proteases, and other molecules that promote inflammatory processes such as leukocyte recruitment, tissue swelling, and pro-inflammatory cytokine production in the tumor microenvironment.\"},{\"question\":\"What roles do IL-37 and IL-38 play in inflammatory signaling?\",\"answer\":\"IL-37 directly reduces inflammation by blocking pathways like NF-κB and MAPK, while IL-38 regulates the IL-36/IL-17 axis. Both can block IL-1 downstream inflammatory cascades.\"},{\"question\":\"Why might blocking IL-1 with IL-37 or IL-38 be a therapeutic strategy?\",\"answer\":\"The review proposes that IL-1 released downstream of oncogenic activity can trigger inflammation through cytokines such as IL-6, TNF, and IL-33. Using IL-37 or IL-38 to block IL-1 may help counter tumor-associated inflammation, especially when combined with other treatments.\"}]","Mast Cells Accumulate in the Stroma of Breast Adenocarcinoma and Secrete Pro-Inflammatory Cytokines and Tumor-Damaging Mediators - Could IL-37 and IL-38 Play an Anti-Tumor Role? | PDF",1790085364,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c03dc114088c5f5e018369a542a8508.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/769d94400692e743336fc683a6f0c96e.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6bc9a3090232572476d86113c49119e.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e84fa2fc5a5d76769e527ced65b8a62.webp",980,1385]